Table 3.

Carfilzomib Safety Data

Adverse Event	Combination Data11 (%)	Monotherapy Data10 (%)
Incidence ≥ 10%
Anemia	42.6	22
Neutropenia	37.8	15
Thrombocytopenia	29.1	29
Fatigue	32.9	37
Diarrhea	42.3	24
Pyrexia	28.6	15
Hypokalemia	27.6	N/A
Hypertension	14.3	N/A
Incidence < 10%
Acute renal failure	8.4	1.5
Cardiac failure	6.4	3.8
Deep vein thrombosis	6.6	N/A
Hypophosphatemia	N/A	7.1